(S (NP-SBJ (NP Activation/NN) (PP of/IN (NP the/DT human/JJ immunodeficiency/NN virus/NN type/NN 1/CD enhancer/NN))) (VP is/VBZ not/RB (ADJP-PRD dependent/JJ (PP on/IN (NP NFAT-1/NN)))) ./.)
(S (NP-SBJ-33 (NP The/DT function/NN) (PP of/IN (NP a/DT putative/JJ NFAT-1/NN site/NN)) (PP in/IN (NP the/DT human/JJ immunodeficiency/NN virus/NN type/NN 1/CD enhancer/NN))) (VP has/VBZ (VP been/VBN (VP analyzed/VBN (NP *-33/-NONE-)))) ./.)
(S (NP-SBJ-34 (NP Activation/NN) (PP by/IN (NP the/DT T-cell/NN antigen/NN receptor/NN))) (VP-COOD (VP is/VBZ (ADJP-PRD minimal/JJ) (PP in/IN (NP Jurkat/NN cells/NNS))) and/CC (VP is/VBZ (VP mediated/VBN (NP *-34/-NONE-) (PP by/IN (NP-LGS the/DT kappa/NN B/NN sites/NNS))))) ./.)
(S-COOD (S (NP-SBJ-35 The/DT putative/JJ NFAT-1/NN region/NN) (VP is/VBZ not/RB (VP required/VBN (NP *-35/-NONE-) (PP for/IN (NP (NP the/DT response/NN) (PP-COOD (PP to/TO (NP anti-CD3/NN)) or/CC (PP to/TO (NP mitogens/NNS))) (PP in/IN (NP (NP-COOD (NP T-cell/NN) ,/, (NP B-cell/NN) ,/, or/CC (NP monocyte\/macrophage/NN leukemia/NN)) lines/NNS))))))) ,/, nor/CC (SINV (VP is/VBZ) (NP-SBJ it/PRP) (NP-PRD a/DT cis-acting/JJ negative/JJ regulatory/JJ element/NN)) ./.)
